Advertisement

Topics

Affymax Raises $50M

11:36 EDT 18 Mar 2011 |

Affymax (NASDAQ: AFFY), the Palo Alto, CA-based developer of an anemia drug, said today it has raised $50 million in gross proceeds through a stock offering. The company sold about 8.47 million new shares at $5.90 apiece, about an 8.5 percent discount from yesterday’s closing stock price of $6.45. Lazard Capital Markets and Stifel Nicolaus [...]

Original Article: Affymax Raises $50M

NEXT ARTICLE

More From BioPortfolio on "Affymax Raises $50M"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...